c-Flip overexpression reduces cardiac hypertrophy in response to pressure overload

Journal of Hypertension

Volumn 26, Issue 5, 2008, Pages 1008-1016

  Giampietri, Claudia ^a   Petrungaro, Simonetta ^a   Musumeci, Marco ^c   Coluccia, Pierpaolo ^a   Antonangeli, Fabrizio ^a   De Cesaris, Paola ^b   Filippini, Antonio ^a   Marano, Giuseppe ^c   Ziparo, Elio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Heart; Hypertrophy; Transgenic animal model

Indexed keywords

FLICE INHIBITORY PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA CONSTRICTION; APOPTOSIS; ARTICLE; CARDIOPULMONARY HEMODYNAMICS; CONTROLLED STUDY; ELECTROCARDIOGRAPHY MONITORING; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE FUNCTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TISSUE SECTION; TRANSGENIC MOUSE; WILD TYPE;

EID: 42049095914     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3282f6a179     Document Type: Article

References (32)

1. Callus BA, Vaux DL. Caspase inhibitors: viral, cellular and chemical. Cell Death Differ 2007; 14:73-78.
2. Roos WP, Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol Med 2006; 12:440-450.
3. Peter ME. The flip side of FLIP. Biochem J 2004; 382:e1-e3.
4. Giampietri C, Petrungaro S, Klinger FG, Coluccia P, Paone A, Vivarelli E, et al. c-Flip expression and function in fetal mouse gonocytes. FASEB J 2006; 20:124-126.
5. Gilot D, Serandour AL, Ilyin GP, Lagadic-Gossmann D, Loyer P, Corlu A, et al. A role for caspase-8 and c-FLIPL in proliferation and cell-cycle progression of primary hepatocytes. Carcinogenesis 2005; 26:2086-2094.
6. Badorff C, Ruetten H, Mueller S, Stahmer M, Gehring D, Jung F, et al. Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload. J Clin Invest 2002; 109:373-381.
7. Nelson DP, Setser E, Hall DG, Schwartz SM, Hewitt T, Klevitsky R, et al. Proinflammatory consequences of transgenic fas ligand expression in the heart. J Clin Invest 2000; 105:1199-1208.
8. Ruwhof C, van der LA. Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. Cardiovasc Res 2000; 47:23-37.
9. Imanishi T, Murry CE, Reinecke H, Hano T, Nishio I, Liles WC, et al. Cellular FLIP is expressed in cardiomyocytes and down-regulated in TUNEL-positive grafted cardiac tissues. Cardiovasc Res 2000; 48:101-110.
10. Yeh WC, Itie A, Elia AJ, Ng M, Shu HB, Wakeham A, et al. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 2000; 12:633-642.
11. Giuili G, Tomljenovic A, Labrecque N, Oulad-Abdelghani M, Rassoulzadegan M, Cuzin F. Murine spermatogonial stem cells: targeted transgene expression and purification in an active state. EMBO Rep 2002; 3:753-759.
12. Huber S, Dohrman A, Sartini D, Budd RC. Reduced myocarditis following Coxsackievirus infection in cellular FLICE inhibitory protein-long form-transgenic mice. Immunology 2006; 119:541-550.
13. Oehme I, Neumann F, Bosser S, Zornig M. Transgenic overexpression of the Caspase-8 inhibitor FLIP(short) leads to impaired T cell proliferation and an increased memory T cell pool after staphylococcal enterotoxin B injection. Eur J Immunol 2005; 35:1240-1249.
14. Tai TS, Fang LW, Lai MZ. c-FLICE inhibitory protein expression inhibits T-cell activation. Cell Death Differ 2004; 11:69-79.
15. + exchange inhibition attenuates left ventricular remodeling and preserves systolic function in pressure-overloaded hearts. Br J Pharmacol 2004; 141:526-532.
16. Rockman HA, Ross RS, Harris AN, Knowlton KU, Steinhelper ME, Field LJ, et al. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci U S A 1991; 88:8277-8281.
17. Yuan JS, Reed A, Chen F, Stewart CN Jr. Statistical analysis of real-time PCR data. BMC Bioinformatics 2006; 7:85.
18. Haq S, Choukroun G, Kang ZB, Ranu H, Matsui T, Rosenzweig A, et al. Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy. J Cell Biol 2000; 151:117-130.
19. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995; 378:785-789.
20. Gurdal H, Bond RA, Johnson MD, Friedman E, Onaran HO. An efficacy-dependent effect of cardiac overexpression of beta2-adrenoceptor on ligand affinity in transgenic mice. Mol Pharmacol 1997; 52:187-194.
21. DeBosch B, Sambandam N, Weinheimer C, Courtois M, Muslin AJ. Akt2 regulates cardiac metabolism and cardiomyocyte survival. J Biol Chem 2006; 281:32841-32851.
22. Meguro T, Hong C, Asai K, Takagi G, McKinsey TA, Olson EN, Vatner SF. Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure. Circ Res 1999; 84:735-740.
23. Oie E, Bjornerheim R, Clausen OP, Attramadal H. Cyclosporin A inhibits cardiac hypertrophy and enhances cardiac dysfunction during postinfarction failure in rats. Am J Physiol Heart Circ Physiol 2000; 278:H2115-H2123.
24. Hill JA, Karimi M, Kutschke W, Davisson RL, Zimmerman K, Wang Z, et al. Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation 2000; 101:2863-2869.
25. Esposito G, Rapacciuolo A, Naga Prasad SV, Takaoka H, Thomas SA, Koch WJ, Rockman HA. Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation 2002; 105:85-92.
26. Kong Y, Tannous P, Lu G, Berenji K, Rothermel BA, Olson EN, Hill JA. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 2006; 113:2579-2588.
27. Rogers JH, Tamirisa P, Kovacs A, Weinheimer C, Courtois M, Blumer KJ, et al. RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload. J Clin Invest 1999; 104:567-576.
28. Marano G, Palazzesi S, Fadda A, Vergari A, Ferrari AU. Attenuation of aortic banding-induced cardiac hypertrophy by propranolol is independent of beta-adrenoceptor blockade. J Hypertens 2002; 20:763-769.
29. Nagata S. Apoptosis by death factor. Cell 1997; 88:355-365.
30. Wollert KC, Heineke J, Westermann J, Ludde M, Fiedler B, Zierhut W, et al. The cardiac Fas (APO-1/CD95) Receptor/Fas ligand system: relation to diastolic wall stress in volume-overload hypertrophy in vivo and activation of the transcription factor AP-1 in cardiac myocytes. Circulation 2000; 101:1172-1178.
31. Bouillet P, Oulad-Abdelghani M, Vicaire S, Garnier JM, Schuhbaur B, Dolle P, Chambon P. Efficient cloning of cDNAs of retinoic acid-responsive genes in P19 embryonal carcinoma cells and characterization of a novel mouse gene, Stra1 (mouse LERK-2/Eplg2). Dev Biol 1995; 170:420-433.
32. Pan J, Baker KM. Retinoic acid and the heart. Vitam Horm 2007; 75:257-283.